Recent Headlines
IonSense, Inc. Presenting Direct Analysis in Real Time (DART®) Mass Spectrometry at the 6th International Symposium on Recent Advances in Food Analysis (RAFA)
IonSense Exhibiting at RAFA, November 5-8, 2013 in Prague, Czech Republic. Customer Workshop Will Feature High Sensitivity Analysis Using Sorbent Technologies Coupled with DART. - November 04, 2013 - IonSense, Inc.
Clinical Trials GPS Launches New Patient Dashboard, Suggests Trials Based on Condition and Location, Connects Research Facilities with Patients in the U.S.
While government health sites remain behind the times, Clinical Trials GPS provides patients with up to date trial and facility data, new patient dashboard and study promotion tools for research sites. - November 03, 2013 - Clinical Trials Institute
Leading Edge Medical Extends Invitations to Luminaries
Hong Kong-based LEMed has extended invitations to two stem cell pioneers to join its Science Advisory Board. - November 03, 2013 - Leading Edge Medical, Ltd.
epDualfilter TIPS® and Pipette.com’s Tips for Rainin LTS® Pipettes Now Available at Pipette.com
Pipette.com, liquid handling experts for over 17 years, announces an expansion of their tip offering with epDualfilter TIPS® as well as Pipette.com’s alternative tips for Rainin LTS® tips. The expansion will benefit labs looking to get more accurate and precise lab results. - November 02, 2013 - Pipette.com
AveXis-BioLife Launch New Website
AveXis-BioLife is pleased to announce the launch of the company’s brand new website: www.avexisinc.com. The October 2013 unveiling of the website coincides with the company’s licensing of the gene therapy program from The Kaspar Laboratory for the treatment of Spinal Muscular Atrophy... - November 01, 2013 - AveXis Inc.
MOgene LC Announces the Addition of Illumina HiSeq
MOgene LC, a full service genomics service provider, announces the addition of Illumina HiSeq to further expand its offerings. “MOgene is continually striving to become a one stop shop for genomics services. Expanding our service offerings allows us to partner with our customers and provide... - October 30, 2013 - MOgene, LC
ALPCO Expands Product Offering with Addition of Mouse-Specific Flow Cytometry Reagents
Earlier this year, ALPCO began offering flow cytometry reagents and data analysis software. As promised, the company has recently added high quality and affordable mouse reagents to their growing flow cytometry portfolio. Among the 600 new mouse reagents are antibodies for CD3, CD4, CD8 and... - October 29, 2013 - ALPCO
ASAlaser at Medica 2013, Düsseldorf: Under the Sign of Internationalization
The most important world fair of medicine and hospital technique is staged for industry excellences. Even ASAlaser, already well-know for Hilterapia® and MLS®, will be in Düsseldorf with the full range of its devices including new solutions for dental and veterinary use. - October 28, 2013 - ASA srl
Colorado BioScience Association Announces Finalists for 2013 "Company of the Year" and "Rising Star" of the Year Awards
The Colorado BioScience Association (CBSA) has released the finalists for the 2013 “Company of the Year” and “Rising Star” Awards, which they will present during the Annual Awards Dinner held on Thursday, November 7, at the Marriott City Center, 1701 California Street, Denver, CO. - October 28, 2013 - Colorado BioScience Association
DNA Diagnostics Centre (DDC), One of the World’s Largest DNA Testing Companies, Increases the Identification Power of Its DNA Tests by More Than 500%
DDC (DNA Diagnostics Centre) and it’s division, DDC Medical, one of the world’s largest providers of DNA tests, announced today that all DNA tests utilising Short Tandem Repeat (STR) DNA testing technology, including Paternity and Cell Line Authentication testing, will now examine 22... - October 26, 2013 - DNA Diagnostics Centre
Pipette.com Launches New Blog Solutions.Pipette.com to Help Scientists Find Liquid Handling Answers
Liquid handling experts, Pipette.com has launched their blog site Solutions.Pipette.com. The new site will benefit the Life Science community by making it easier to find the best products and services that fit any lab technician’s problem. These resources include articles, promotions, product... - October 25, 2013 - Pipette.com
ALPCO Launches STELLUX™ Chemiluminescent Human Insulin ELISA
ALPCO releases second chemiluminescent assay in STELLUX™ product line. - October 24, 2013 - ALPCO
Fertility Preservation Network Sponsors Reno and Dallas Race for the Cure Teams
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in Susan G. Komen for the Cure fundraisers. - October 24, 2013 - ReproTech, LLC
Nuliv Science to Attend SupplySide West 2013
Expo for Ingredient Buyers and Sellers from Around the World - October 24, 2013 - Nuliv Science
Leading Edge Medical Survey Reflects Keen Interest of Medical Professionals
LEMed survey indicates one third of stem cell doctors are interested in laser-medical therapies for their patients. - October 23, 2013 - Leading Edge Medical, Ltd.
DrugDev and CFS Clinical Come Together to Drive Clinical Trial Standards for Investigators, CROs and Sponsors
DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced today its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials. DrugDev and... - October 23, 2013 - Clinical Financial Services
Leading Edge Medical to Create New Therapies to Improve Stem Cell Results
Leading Edge Medical to open new clinic that will offer the most advanced protocols and techniques in cellular medicine and laser treatment technology. - October 22, 2013 - Leading Edge Medical, Ltd.
AveXis-BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Children's Hospital and The Ohio State University
BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio. The license... - October 21, 2013 - AveXis Inc.
Leading Edge Medical in Discussions with German Laser-Medicine World-Leader
Hong Kong-based LEMed have scheduled meetings with head of Germany’s Weber Medical this week in Hong Kong. - October 21, 2013 - Leading Edge Medical, Ltd.
Paid Migraine Clinical Trial Now Enrolling at Achieve Clinical Research Near Birmingham, Alabama; Accepting M/F Patients Suffering from Migraines Age 18 - 75
Achieve is conducting a randomized, single-dose study comparing the efficacy and safety of a combination of acetaminophen and aspirin vs placebo in the acute treatment of migraine headaches. - October 18, 2013 - Clinical Trials Institute
AveXis BioLife Announce The Research Institute at Nationwide Children’s Hospital Received Fast Track Status for Spinal Muscular Atrophy Treatment
AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children’s Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular... - October 18, 2013 - AveXis Inc.
Paid Rheumatoid Arthritis (RA) Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with RA Age 18 - 75
Achieve is conducting a study to evaluate the safety and efficacy of a new drug versus rituximab in patients with moderately to severely active rheumatoid arthritis (RA). - October 16, 2013 - Clinical Trials Institute
The Colorado BioScience Association Celebrates 10 Years of Supporting Bioscience in Colorado at the Annual Awards Dinner
The Colorado BioScience Association (CBSA) is celebrating its 10th Anniversary with special honors during its Annual Awards Dinner at the Denver Marriott City Center. This year’s event will feature three very special honors given only for the 10th anniversary, including the Pioneering Award, Founders Award and Visionary Award. - October 16, 2013 - Colorado BioScience Association
Good News for Drug Delivery Researchers: AbboMax, Inc. Offers a Portfolio of Innovative Liposome Reagents
Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer. The liposomes can be filled with different substances and used as vehicles for drug or nutrient delivery. AbboMax offers various innovative liposome reagents with a large number of lipid compositions to support the needs of research organizations involved in liposome drug delivery. - October 16, 2013 - AbboMax, Inc.
Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate (ADC) Levels
Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. - October 12, 2013 - Epitope Diagnostics, Inc.
American Clinical Solutions Has Unveiled a New Testing Service for Delta 9-Tetrahydrocannabinol (THC) in Oral Fluid
For patients with a history of chronic marijuana use, detection of urine THC-COOH might not be able to help physicians determine a patient’s current status of marijuana use. - October 10, 2013 - American Clinical Solutions
Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference
Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013 - Rosa & Co LLC
ReproTech Founder Receives American Association of Tissue Banks Award
The American Association of Tissue Banks recognized Russell Bierbaum, ReproTech, Ltd. founder and former President, for his contributions to the tissue banking industry this week at its annual meeting. - October 06, 2013 - ReproTech, LLC
HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2
Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding
The Changing Environment for Pharma and Medtech Companies in Europe
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+
Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD). - September 29, 2013 - Clinical Trials Institute
Your Stem Cell Success Stories Can Help Bring Hope to Others
HopeCell.org Founders Invite Stem Cell Patients to Share Their Experiences and Successes - September 29, 2013 - HopeCell
Pipette.com Announces Promotional T-Shirt and Other Specials for Neuroscience 2013
Pipette.com, distributor of liquid handling products, is attending Neuroscience 2013. They will be answering questions, demoing products, and raffling promotional t-shirts in Booth #3331. - September 28, 2013 - Pipette.com
Nuliv Science Announces ActiGin – the Ultimate Endurance and Sports Intensity Booster
Nuliv Science, a research focused ingredient supplier, today announced the release of their proprietary ingredient ActiGin, the all-natural sports supplement and muscle recovery supplement enhances endurance and intensity for athletes and active adults and allows them to achieve peak... - September 26, 2013 - Nuliv Science
Nuliv Science Introduces AstraGin - the Ultimate Nutrient Absorption Enhancer
Nuliv Science, a scientifically proven ingredient supplier, today announced the release of their proprietary ingredient AstraGin, the ultimate nutrient absorption enhancer and best pre-workout supplement, that significantly promotes and improves the absorption of amino acids, glucose and vitamins... - September 26, 2013 - Nuliv Science
Multichannel Pipettes Promotion Now Available at Pipette.com
Pipette.com, major distributor of liquid handling products, has announced their extension of promotions on multichannel pipettes. The promotions will help labs increase productivity. - September 26, 2013 - Pipette.com
Nuliv Science to Attend Prestigious 2013 Olympia Fitness and Performance Expo
Nuliv Science, a research focused ingredient supplier, today announced they will be in attendance at the 2013 Mr. Olympia Fitness and Performance Expo held at the Las Vegas Convention Center. The weekend long event will showcase some of the industry's most prominent business vendors, participants... - September 25, 2013 - Nuliv Science
StemCells21 to Open Second Luxury Medical Center
StemCells21 Company will open its second 5* medical facility. The new addition will feature state-of-the-art operation rooms, Cellular medicine laboratories and compounding nutrition & Hormone laboratories. All of which will be constructed to the highest standards and all class 10,000 clean room grade. - September 22, 2013 - StemCells21
Colorado BioScience Association Partners with Two of the State’s Economic Development Entities to Promote Colorado’s Strengths at AdvaMed 2013
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostic sectors during the 2013 AdvaMed: The MedTech Conference in Washington D.C., September 23-25. - September 20, 2013 - Colorado BioScience Association
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
ReproTech Sponsors Twin Cities Pancreatic Cancer Fundraising Event
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was a sponsor for the Twin Cities PurpleRide to benefit the Pancreatic Cancer Action Network (PANCAN) - September 18, 2013 - ReproTech, LLC
30+ Life Science Investors & Strategic Partners Convene in Denver This Week for 2013 Rocky Mountain Life Science Investor & Partnering Conference
More than 30 leading investors and strategic partners from across the country will come to Denver to connect and invest in the region's emerging life science companies at the 2013 Rocky Mountain Life Science Investor & Partnering Conference. Spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — the conference opens with a reception at the Colorado Governor’s Mansion September 18th. - September 16, 2013 - Colorado BioScience Association
AveXis Inc. Names Director, Scientific and Corporate Affairs
AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Mindy Du as the company’s new Director of Scientific and Corporate Affairs. This is an essential position within the company, as AveXis is focused on research/development of leading-edge technology for disease... - September 13, 2013 - AveXis Inc.
NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development
The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita
American Clinical Solutions Releases a New Confirmatory Test for Alcohol Exposure
Alcohol abuse is a serious public health issue in the United States. American Clinical Solutions routinely conducts alcohol tests in urine and oral fluid samples. - September 06, 2013 - American Clinical Solutions
American Clinical Solutions Releases Study "Alprazolam- Used and Abused"
American Clinical Solutions provides testing service for alprazolam and alphahydroxy alprazolam in urine and oral fluid. - September 03, 2013 - American Clinical Solutions
American Clinical Solutions Releases Breakthrough Testing Service for Acetyl Fentanyl
To help combat acetyl fentanyl abuse, American Clinical Solutions is going to offer a UPLC/MS based testing service for acetyl fentanyl in urine and oral fluid. - September 03, 2013 - American Clinical Solutions
Leading CEOs Keynote 2013 Rocky Mountain Life Science Investor & Partnering Conference in Denver
CEOs from Clovis Oncology and Array BioPharma will keynote the opening breakfast at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) September 19 at The Ritz-Carlton, Denver. In addition, the conference luncheon will feature Jeff Calcagno, M.D., Principal, Venture Investments, Johnson & Johnson Development Corporation. - September 03, 2013 - Colorado BioScience Association
Integrative Medicine for Appetite Control: Binge Eating, Obesity, and Anorexia
Dr. James Greenblatt, M.D., will be presenting on Integrative Medicine for Appetite Control at the 4th Annual Integrative Medicine for Mental Health Conference in Chicago, IL, September 20-22, 2013. - September 01, 2013 - Integrative Medicine for Mental Health
SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event
SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd